Amprius: drone batteries doubled sales, but the cash still runs out the door

Revenue up 126%, gross margin from 9% to 27%, a $75M Pentagon award. But receivables are piling up, the stock sits near its 52-week low, and Q3 is days away.

By A (Akash Chaudhari), 2026-11-06

Price is the Nov 6, 2026 close. Q3 results are due next week. Research only, not advice.

Price$8.16Nov 6 close; 52-wk $7.02–24.23
Revenue, Q2$34.0M+126% y/y
Gross margin, Q227%was 9%
Operating cash, H1−$40.1Mworse than the loss
Cash$74.5Mdebt $6.4M
EV / 2026 sales~8xat the $140M guide

What Amprius sells and who buys it

Amprius makes lithium-ion cells with a silicon anode instead of graphite. Silicon stores far more lithium, so a cell of the same weight holds more energy. For a drone, that means longer flights or bigger payloads. For a defense customer, it means a longer mission. The SiCore line was 98% of revenue in Q2.

This is not an AI stock. It is a drone stock, and drones are the theme. As CEO Tom Stepien put it on the Q2 call: "low-cost drones are playing an asymmetric role in military conflicts around the world, changing the nature of modern warfare." The customer list shows it:

Amprius does not build most of its cells itself. It designs them and pays contract manufacturers to produce them: Berzelius (a former affiliate), four partners in China, and a group of South Korean partners (the "Amprius Korea Battery Alliance"). Together they give access to more than 2.0GWh a year. That is why revenue could double without big capex: capex is guided under $10M for 2026.

Quarterly revenue$M
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
$34M
Q2 26▲ 19%
The 2026 guide of at least $140M implies about $39M a quarter in the second half

Sources